cyclosporine and Lung Neoplasms

cyclosporine has been researched along with Lung Neoplasms in 76 studies

Research

Studies (76)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	29 (38.16)	18.2507
2000's	25 (32.89)	29.6817
2010's	20 (26.32)	24.3611
2020's	2 (2.63)	2.80

Authors

Authors	Studies
Cerqueira, F; Florêncio, MH; Justino, F; Marcelo-Curto, MJ; Moiteiro, C; Nascimento, MS; Pedro, M; Pinto, MM; Tavares, R	1
Chen, S; Ji, X; Jin, J; Zhang, H; Zhao, L; Zhao, M	1
Cang, S; Chen, F; Jiang, L; Liu, C; Wei, W; Zhang, H	1
Asano, K; Enokida, K; Hattori, S; Hayama, N; Hirabayashi, K; Horio, Y; Ito, Y; Miyaoka, M; Niimi, K; Oguma, T; Ohshinden, K; Takahashi, F; Takahashi, G; Takahashi, M; Takiguchi, H; Takihara, T; Tanaka, J	1
Fang, Y; Han, W; Jiang, H; Jiang, L; Li, Y; Liu, Z; Pan, H; Wang, Z; Xie, B; Xie, J; Zhou, X	1
Chen, Z; Qin, X	1
Cikes, M; Hecimovic, A; Jakopovic, M; Jankovic Makek, M; Samarzija, M; Vukic Dugac, A	1
Lu, JH; Shi, ZF; Xu, H	1
Du, HX; Jiang, J; Tu, YR; Yao, CC; Ye, SF; Zhang, Y	1
Hui, PP; Kai, S; Lu, JH; Zhao, H	1
Bertelsen, T; Fogh, K	1
Behnam-Motlagh, P; Brännström, T; Grankvist, K; Gudey, SK; Johansson, A; Karlsson, T; Tyler, A	1
Dotor, A; González-Herrada, C; Lapresta, A	1
Ban, HS; Im, JY; Kim, BK; Kim, YJ; Lee, KW; Lee, YJ; Song, KB; Won, KJ; Won, M; Yoon, SH	1
Diem, S; Larkin, J; Spain, L	1
Aljadir, DN; Boils, CL; Cantafio, AW	1
Han, W; Jiang, L; Jing, J; Jing, Z; Pan, H; Shou, J; Sui, X; Xie, J; Yao, J; You, L	1
Catania, C; Curigliano, G; de Braud, F; De Carlis, L; De Pas, T; Locatelli, M; Lorizzo, K; Pelosi, G; Spitaleri, G; Toffalorio, F	1
Boffa, DJ; Hojo, M; Luan, FL; Maluccio, M; Suthanthiran, M	1
Dai, Y; Li, F; Li, Y; Wong, ST; Xia, X; Yang, J; Zhou, X	1
Krecipro-Nizińska, E; Morgiel, E; Smiechowicz, H; Wiland, P	1
Braissant, O; Buclin, T; Decosterd, LA; Henry, H; Krueger, T; Kuemmerle, A; Ris, HB; Yan, H	1
Fukunaga, M; Gon, Y; Hashimoto, S; Mizumura, K; Sato, M; Takahashi, N; Tsujino, I	1
Anidjar, M; Chevalier, S; Cury, FL; Hamel, L; Luz, M; Rocha, J; Scarlata, E	1
Abbas, AA; Jastaniah, WA	1
Baas, P; Beijnen, JH; Keilholz, U; Kruijtzer, CM; Marcus, S; Mathôt, RA; Mezger, J; Rosing, H; Schellens, JH; Scheulen, ME; van Tinteren, H	1
Coffey, MC; Hirasawa, K; Lee, PW; Nishikawa, SG; Norman, KL; Thompson, BG; Waisman, DM; Yoon, CS	1
Chon, WJ; Ding, R; Lagman, M; Luan, FL; Sharma, VK; Suthanthiran, M	1
Mogayzel, PJ; Wagner, TL	1
Chada, S; Hunt, KK; Pataer, A; Roth, JA; Swisher, SG	1
Boffa, DJ; Lagman, M; Luan, F; Sharma, VK; Suthanthiran, M; Thomas, D; Yang, H	1
Fujioka, T; Ishida, Y; Numaoka, H; Omori, S; Ono, Y	1
Gilbert, BE; Golunski, E; Knight, V; Koshkina, NV; Roberts, LE	2
Black, JL; Borger, P; Burgess, JK; Glanville, AR; Hostettler, KE; Johnson, PR; Roth, M; Tamm, M	1
Dermitzakis, A; Ekonomidou, F; Karalis, I; Tsoussis, S; Vourliotaki, E	1
Campa, MJ; Fitzgerald, MC; Howard, BA; Patz, EF; Shetty, JT; Wang, MZ	1
Almaraz, A; Blanco, G; Fernández, N; López-Velasco, R; Morilla-Grasa, A; Ordóñez, JL; Rábano, G; Saornil-Alvarez, MA	1
Bishop, PW; Ekren, PK; Kabasakal, Y; Mogulkoc, N	1
Chen, Y; Huang, LN; Li, BQ; Li, DM; Li, W; Xia, XM; Zhou, JH	1
Bette, M; Dünne, AA; Häussler, U; Heverhagen, JT; Mandic, R; Neubauer, A; Schulz, S; Weihe, E; Werner, JA	1
Besenzon, L; Bianchi, M; Brach Del Prever, A; Briccoli, A; Massara, FM; Miniero, R; Picci, P	1
Hunt, S; Johnson, F	1
Jamal, SA; Murphy, GF; Siu, LL; Skorecki, KL; Tobe, SW; Warner, E	1
Klaff, RA	1
Anderson, R; Jooné, GK; Myer, MS; O'Sullivan, JF; Van Rensburg, CE	1
de Vries, EG; Meersma, GJ; Mesander, G; Mulder, NH; Timmer-Bosscha, H; van der Graaf, WT; Vellenga, E	1
Rayner, S; Rhodes, T; Twentyman, PR	1
Piscitelli, SC; Plank, GS; Raber, SR; Rodvold, KA; Rushing, DA; Tewksbury, DA	1
Bar-Shira-Maymon, B; Dayan-Avidan, G; Donin, N; Leibovici, J; Michowitz, M	1
Carmichael, J; Harris, AL; Kirk, J; Stratford, IJ	1
Barrand, MA; Center, MS; Rhodes, T; Twentyman, PR	1
Pollard, M	1
Osann, K; Slater, LM; Stupecky, M; Sweet, P	1
Cleary, I; Clynes, M; Connolly, L; Heenan, M; O'Driscoll, L	1
Cleary, I; Clynes, M; Doherty, G; Moran, E	1
Aebischer, MC; Braathen, LR; Zala, LB	1
Cho, J; Downey-Hurtado, N; Osann, K; Ramsinghani, N; Ross, HJ; Slater, LM; Williams, J; Wong, SF	1
Cowie, FJ; Pinkerton, CR; Pritchard-Jones, K; Renshaw, J	1
Anderson, R; Jooné, G; Van Rensburg, CE	1
Albertson, T; Allen, R; Follette, D; Katznelson, S; Roberts, P	1
Paquet, P; Piérard, GE	1
Hanibuchi, M; Parajuli, P; Shrivastava, P; Sone, S; Tsuruo, T; Yano, S	1
Chan, MW; Chiang, CD; Song, EJ; Yang, VC	1
Ascher, NL; Ferrell, L; Freise, CE; Liu, T; Roberts, JP	1
Hosenpud, JD; Khanna, AK	1
de Vries, EG; Eriks-Fluks, L; Franssen, EJ; Hendrikse, NH; Hospers, GA; Vaalburg, W; van der Graaf, WT; Willemsen, AT	1
Gekeler, V; Hofmann, HP; Schäfer, M; Stoeck, M	1
Lie, SO; Smevik, B; Storm-Mathisen, I; Zeller, B	1
Blanco, G; Diebold, Y; Domingo, E; López, R; Rábano, G; Saornil, AM; Tutor, CJ	1
Beijnen, JH; Duchin, K; Koopman, FJ; Lieverst, J; Malingré, MM; Rosing, H; Schellens, JH; Swart, M; ten Bokkel Huinink, WW; van Tellingen, O	1
Osborn, FD; Sebelik, ME; Snowden, RT; Wong, FS	1
Lake, J; Levy, G; Thervet, E; Uchida, K	1
Twentyman, PR; Wallace, HM; Wright, KA	1
Alpeter, MD; Glisson, BS	1
Chino, T; Kage, T; Mogi, M; Nakajima, J; Ueda, A; Yamada, T	1

Reviews

4 review(s) available for cyclosporine and Lung Neoplasms

Article	Year
Management of toxicities of immune checkpoint inhibitors. Cancer treatment reviews, 2016, Volume: 44 Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antilymphocyte Serum; Antineoplastic Agents; Carcinoma, Renal Cell; Chemical and Drug Induced Liver Injury; Colitis; CTLA-4 Antigen; Cyclosporine; Diarrhea; Drug Eruptions; Humans; Immunosuppressive Agents; Infliximab; Ipilimumab; Kidney Neoplasms; Lung Neoplasms; Melanoma; Mycophenolic Acid; Neoplasms; Nivolumab; Pituitary Diseases; Programmed Cell Death 1 Receptor; Skin Neoplasms; Tacrolimus; Thyroiditis	2016
Successful treatment of idiopathic thrombocytopenic purpura-like syndrome in a cancer patient with low-dose interferon: case report and review of the literature. American journal of hematology, 2004, Volume: 76, Issue:4 Topics: Aged; Autoimmune Diseases; Carcinoma, Small Cell; Cyclosporine; Drug Resistance; Drug Resistance, Neoplasm; Fatal Outcome; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Interferon alpha-2; Interferon-alpha; Lung Neoplasms; Male; Platelet Count; Prednisolone; Purpura, Thrombocytopenic, Idiopathic; Recombinant Proteins; Remission Induction; Vincristine	2004
Superficial leiomyosarcoma of the head and neck: case report and review of the literature. Ear, nose, & throat journal, 2001, Volume: 80, Issue:7 Topics: Cyclosporine; Diagnosis, Differential; Fatal Outcome; Head and Neck Neoplasms; Heart Transplantation; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Leiomyosarcoma; Lung Neoplasms; Male; Middle Aged; Skin; Skin Neoplasms; Tomography, X-Ray Computed	2001
Patient management by Neoral C(2) monitoring: an international consensus statement. Transplantation, 2002, May-15, Volume: 73, Issue:9 Suppl Topics: Adult; Child; Cyclosporine; Drug Monitoring; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Kidney Transplantation; Liver Transplantation; Lung Neoplasms	2002

Trials

5 trial(s) available for cyclosporine and Lung Neoplasms

Article	Year
Phase II and pharmacologic study of weekly oral paclitaxel plus cyclosporine in patients with advanced non-small-cell lung cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002, Dec-01, Volume: 20, Issue:23 Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cyclosporine; Disease-Free Survival; Drug Administration Schedule; Female; Humans; Immunosuppressive Agents; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Survival Analysis; Treatment Outcome	2002
Treatment with ozone/oxygen-pneumoperitoneum results in complete remission of rabbit squamous cell carcinomas. International journal of cancer, 2008, May-15, Volume: 122, Issue:10 Topics: Animals; Anti-Inflammatory Agents; Body Weight; Carcinoma, Squamous Cell; Cyclosporine; Dexamethasone; Head and Neck Neoplasms; Immunosuppressive Agents; Lung Neoplasms; Oxygen; Ozone; Pneumoperitoneum; Rabbits; Remission Induction; Survival Rate	2008
Vinblastine and erythromycin: an unrecognized serious drug interaction. Cancer chemotherapy and pharmacology, 1995, Volume: 35, Issue:3 Topics: Aged; Carcinoma, Renal Cell; Constipation; Cyclosporine; Drug Synergism; Drug Therapy, Combination; Erythromycin; Humans; Kidney Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Muscle Spasticity; Neutropenia; Pain; Vinblastine	1995
Phase I/II trial of low dose cyclosporin A with EP for advanced non-small cell lung cancer. Lung cancer (Amsterdam, Netherlands), 1997, Volume: 18, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cyclosporine; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Survival Rate	1997
The effect of different doses of cyclosporin A on the systemic exposure of orally administered paclitaxel. Anti-cancer drugs, 2001, Volume: 12, Issue:4 Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Breast Neoplasms; Carcinoma, Small Cell; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Gastrointestinal Diseases; Hematologic Diseases; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Neoplasms; Paclitaxel; Premedication; Stomach Neoplasms; Uterine Cervical Neoplasms; Uterine Neoplasms	2001

Other Studies

67 other study(ies) available for cyclosporine and Lung Neoplasms

Article	Year
Synthetic secofriedelane and friedelane derivatives as inhibitors of human lymphocyte proliferation and growth of human cancer cell lines in vitro. Journal of natural products, 2001, Volume: 64, Issue:10 Topics: Antineoplastic Agents, Phytogenic; Brain Neoplasms; Breast Neoplasms; Chromatography, Thin Layer; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Inhibitory Concentration 50; Kidney Neoplasms; Lung Neoplasms; Lymphocytes; Magnetic Resonance Spectroscopy; Melanoma; Molecular Structure; Oxidation-Reduction; Portugal; Quercus; Structure-Activity Relationship; Triterpenes; Tumor Cells, Cultured	2001
Construction of chitooligosaccharide-based nanoparticles of pH/redox cascade responsive for co-loading cyclosporin A and AZD9291. Carbohydrate polymers, 2022, Sep-01, Volume: 291 Topics: Acrylamides; Aniline Compounds; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Chitosan; Cyclosporine; Drug Delivery Systems; Humans; Hydrogen-Ion Concentration; Indoles; Lung Neoplasms; Nanoparticles; Oligosaccharides; Oxidation-Reduction; Pyrimidines; Tumor Microenvironment	2022
Enhancing the cytotoxic efficacy of combined effect of doxorubicin and Cyclosporin encapsulated photoluminescent graphene dotted mesoporous nanoparticles against lung cancer cell-specific drug targeting for the nursing care of cancer patients. Journal of photochemistry and photobiology. B, Biology, 2019, Volume: 198 Topics: Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cyclosporine; DNA Damage; Doxorubicin; Drug Carriers; Graphite; Humans; Lung Neoplasms; Nanoparticles; Porosity	2019
Regression of Lung Squamous Cell Carcinoma after the Withdrawal of Cyclosporin A Combined with Pirfenidone Treatment in a Patient with Idiopathic Pulmonary Fibrosis. Internal medicine (Tokyo, Japan), 2021, Feb-15, Volume: 60, Issue:4 Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Carcinoma, Squamous Cell; Cyclosporine; Humans; Idiopathic Pulmonary Fibrosis; Lung; Lung Neoplasms; Male; Pyridones; Treatment Outcome	2021
Cyclosporine A sensitizes lung cancer cells to crizotinib through inhibition of the Ca2 EBioMedicine, 2019, Volume: 42 Topics: Antineoplastic Agents; Calcineurin; Calcium; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Survival; Crizotinib; Cyclosporine; Drug Synergism; Extracellular Signal-Regulated MAP Kinases; Gene Amplification; Humans; Lung Neoplasms; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-met; Signal Transduction	2019
Metabolic dependence of cyclosporine A on cell proliferation of human non‑small cell lung cancer A549 cells and its implication in post‑transplant malignancy. Oncology reports, 2019, Volume: 41, Issue:5 Topics: A549 Cells; Acetylcysteine; Carcinogenesis; Carcinoma, Non-Small-Cell Lung; Cell Proliferation; Cyclosporine; Energy Metabolism; Free Radical Scavengers; Glucose; Graft Rejection; Humans; Immunosuppressive Agents; Lung Neoplasms; Organ Transplantation; Palmitic Acid; Reactive Oxygen Species; Signal Transduction	2019
Treatment of EGFR positive lung adenocarcinoma in a heart transplanted patient. Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace, 2019, May-30, Volume: 89, Issue:2 Topics: Adenocarcinoma of Lung; Aged; Antineoplastic Agents; Cyclosporine; Dose-Response Relationship, Drug; Drug Interactions; ErbB Receptors; Erlotinib Hydrochloride; Heart Transplantation; Humans; Immunosuppressive Agents; Lung Neoplasms; Male; Mutation	2019
The mitochondrial cyclophilin D/p53 complexation mediates doxorubicin-induced non-apoptotic death of A549 lung cancer cells. Molecular and cellular biochemistry, 2014, Volume: 389, Issue:1-2 Topics: Animals; Apoptosis; Benzothiazoles; Cell Death; Cell Line; Cell Line, Tumor; Cyclophilins; Cyclosporine; Doxorubicin; HEK293 Cells; Humans; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Mitochondria; Peptidyl-Prolyl Isomerase F; Toluene; Tumor Suppressor Protein p53	2014
β-elemene reverses the drug resistance of lung cancer A549/DDP cells via the mitochondrial apoptosis pathway. Oncology reports, 2014, Volume: 31, Issue:5 Topics: Antineoplastic Agents; Apoptosis; bcl-Associated Death Protein; Caspase 3; Cell Line, Tumor; Cell Proliferation; Cisplatin; Cyclosporine; Cytochromes c; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Glutathione; Humans; Lung Neoplasms; Membrane Potential, Mitochondrial; Mitochondria; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Sesquiterpenes	2014
Pre-clinical evaluation of cinobufotalin as a potential anti-lung cancer agent. Biochemical and biophysical research communications, 2014, Sep-26, Volume: 452, Issue:3 Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Bufanolides; Cell Death; Cell Line, Tumor; Cell Survival; Cyclophilins; Cyclosporine; Drug Evaluation, Preclinical; Gene Expression Regulation, Neoplastic; Humans; Lactones; Lung Neoplasms; Male; Membrane Potential, Mitochondrial; Mice; Mice, Nude; Mitochondria; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Peptidyl-Prolyl Isomerase F; RNA, Small Interfering; Spiro Compounds; Tumor Burden; Xenograft Model Antitumor Assays	2014
[Cancer unmasked or provoked by immunosuppressive therapy]. Ugeskrift for laeger, 2013, Dec-02, Volume: 175, Issue:49A Topics: Aged; Cyclosporine; Female; Humans; Immunosuppressive Agents; Infliximab; Lung Neoplasms; Lymphoma, B-Cell; Male; Middle Aged; Pyoderma Gangrenosum; Vasculitis	2013
Targeting glucosylceramide synthase induction of cell surface globotriaosylceramide (Gb3) in acquired cisplatin-resistance of lung cancer and malignant pleural mesothelioma cells. Experimental cell research, 2015, Aug-01, Volume: 336, Issue:1 Topics: Apoptosis; ATP Binding Cassette Transporter, Subfamily B; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Cell Membrane; Cell Proliferation; Ceramides; Cyclosporine; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flow Cytometry; Glucosyltransferases; Humans; Immunosuppressive Agents; Lung Neoplasms; Meperidine; Mesothelioma; Mesothelioma, Malignant; Microscopy, Confocal; Multidrug Resistance-Associated Proteins; Trihexosylceramides; Tumor Cells, Cultured	2015
Toxic epidermal necrolysis induced by vemurafenib. Actas dermo-sifiliograficas, 2015, Volume: 106, Issue:8 Topics: Aged; Antibodies, Monoclonal; Antineoplastic Agents; Combined Modality Therapy; Cyclosporine; Drug Substitution; Humans; Indoles; Ipilimumab; Lung Neoplasms; Male; Melanoma; Neoplasm Proteins; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Skin Neoplasms; Stevens-Johnson Syndrome; Sulfonamides; Vemurafenib	2015
DNA damage-induced apoptosis suppressor (DDIAS), a novel target of NFATc1, is associated with cisplatin resistance in lung cancer. Biochimica et biophysica acta, 2016, Volume: 1863, Issue:1 Topics: Animals; Apoptosis; Caspase 3; Caspase 7; Cell Line, Tumor; Cisplatin; Cyclosporine; Drug Resistance, Neoplasm; Enzyme Activation; Humans; Lung Neoplasms; Mice; Neoplasm Proteins; NFATC Transcription Factors; Repressor Proteins	2016
Use of the PD-1 Pathway Inhibitor Nivolumab in a Renal Transplant Patient With Malignancy. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2016, Volume: 16, Issue:8 Topics: Aged; Antibodies, Monoclonal; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cyclosporine; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Lung Neoplasms; Male; Nivolumab; Prednisone; Programmed Cell Death 1 Receptor	2016
Cyclosporine A sensitizes human non-small cell lung cancer cells to gefitinib through inhibition of STAT3. Cancer letters, 2016, 08-28, Volume: 379, Issue:1 Topics: A549 Cells; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cyclosporine; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; ErbB Receptors; Female; Gefitinib; Humans; Lung Neoplasms; Mice, Inbred BALB C; Mice, Nude; NFATC Transcription Factors; Phosphorylation; Protein Kinase Inhibitors; Quinazolines; RNA Interference; Signal Transduction; STAT3 Transcription Factor; Time Factors; Transfection; Tumor Burden; Xenograft Model Antitumor Assays	2016
Erlotinib combined with cyclosporine in a liver-transplant recipient with epidermal growth factor receptor-mutated non-small cell lung cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2009, Volume: 4, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cyclosporine; ErbB Receptors; Erlotinib Hydrochloride; Humans; Liver Transplantation; Lung Neoplasms; Male; Middle Aged; Mutation; Quinazolines	2009
Post-transplantation malignancy: a cell autonomous mechanism with implications for therapy. Transactions of the American Clinical and Climatological Association, 2009, Volume: 120 Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cell Line, Tumor; Cyclosporine; Humans; Immunosuppressive Agents; Kidney Neoplasms; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Mice, SCID; Neoplasm Invasiveness; Neoplasms; Organ Transplantation; Phenotype; Sirolimus; Tacrolimus	2009
Image-based chemical screening identifies drug efflux inhibitors in lung cancer cells. Cancer research, 2010, Oct-01, Volume: 70, Issue:19 Topics: Animals; Antineoplastic Agents; ATP-Binding Cassette Transporters; Benzimidazoles; Cell Line, Tumor; Cisplatin; Cyclosporine; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Flow Cytometry; Humans; Lung Neoplasms; Mice; Mice, Inbred NOD; Mice, Nude; Mice, SCID; Microscopy, Fluorescence; Verapamil; Xenograft Model Antitumor Assays	2010
[Nodular changes in lungs in a patient with rheumatoid arthritis. Diagnostic and therapeutic difficulties. Case report]. Annales Academiae Medicae Stetinensis, 2010, Volume: 56 Suppl 1 Topics: Aged; Cyclophosphamide; Cyclosporine; Diagnosis, Differential; Humans; Lung; Lung Neoplasms; Male; Methotrexate; Rheumatoid Nodule	2010
P-glycoprotein modulation by valspodar and cyclosporin does not increase tumor uptake of doxorubicin administered via isolated lung perfusion to rats bearing sarcoma lung metastases. Anticancer research, 2011, Volume: 31, Issue:6 Topics: Animals; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chemotherapy, Cancer, Regional Perfusion; Cyclosporine; Cyclosporins; Doxorubicin; Drug Interactions; Lung Neoplasms; Male; Rats; Rats, Inbred F344; Sarcoma	2011
Cyclosporine A induces apoptosis of human lung adenocarcinoma cells via caspase-dependent pathway. Anticancer research, 2011, Volume: 31, Issue:6 Topics: Adenocarcinoma; Adenocarcinoma of Lung; Apoptosis; Blotting, Western; Caspases; Cell Line, Tumor; Cyclosporine; Cytochromes c; Cytosol; Dose-Response Relationship, Drug; Enzyme Activation; Humans; Isoenzymes; Lung Neoplasms; Mitochondria	2011
Refining the orthotopic dog prostate cancer (DPC)-1 model to better bridge the gap between rodents and men. The Prostate, 2012, May-15, Volume: 72, Issue:7 Topics: Animals; Bone Neoplasms; Carcinoma; Cell Line, Tumor; Cyclosporine; Disease Models, Animal; Dogs; Lung Neoplasms; Lymphatic Metastasis; Male; Neoplasm Transplantation; Prostatic Neoplasms	2012
Extensive gingival and respiratory tract Kaposi sarcoma in a child after allogenic hematopoietic stem cell transplantation. Journal of pediatric hematology/oncology, 2012, Volume: 34, Issue:2 Topics: Child; Cyclosporine; Gingival Neoplasms; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Lung Neoplasms; Male; Prednisolone; Sarcoma, Kaposi; Transplantation, Homologous	2012
Systemic reovirus therapy of metastatic cancer in immune-competent mice. Cancer research, 2003, Jan-15, Volume: 63, Issue:2 Topics: Animals; Carcinoma, Lewis Lung; Combined Modality Therapy; Cyclosporine; Cytopathogenic Effect, Viral; Disease Models, Animal; Female; Immunosuppressive Agents; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Neoplasms, Experimental; Retroviridae	2003
Rapamycin is an effective inhibitor of human renal cancer metastasis. Kidney international, 2003, Volume: 63, Issue:3 Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Cell Cycle; Cell Line, Tumor; Cyclosporine; Gene Expression; Humans; Immunosuppressive Agents; Kidney Neoplasms; Lung Neoplasms; Mice; Mice, SCID; Sirolimus; Survival Rate; Transforming Growth Factor beta; Transforming Growth Factor beta1; Vascular Endothelial Growth Factor A	2003
Cyclosporin and tacrolimus do not potentiate oxidative damage in pulmonary epithelial cells. Transplant international : official journal of the European Society for Organ Transplantation, 2003, Volume: 16, Issue:10 Topics: Adenocarcinoma; Cell Line, Tumor; Cell Survival; Cyclosporine; Humans; Hydrogen Peroxide; Lung Neoplasms; Oxidative Stress; Respiratory Mucosa; Tacrolimus	2003
Adenoviral melanoma differentiation-associated gene 7 induces apoptosis in lung cancer cells through mitochondrial permeability transition-independent cytochrome c release. The Journal of thoracic and cardiovascular surgery, 2003, Volume: 125, Issue:6 Topics: Adenoviridae; Apoptosis; Caspases; Cyclosporine; Cytochrome c Group; Enzyme Activation; Gene Transfer Techniques; Genes, p53; Genes, Tumor Suppressor; Humans; Interleukins; Lung Neoplasms; Membrane Potentials; Mitochondria; Staurosporine; Transduction, Genetic; Tumor Cells, Cultured	2003
Rapamycin inhibits the growth and metastatic progression of non-small cell lung cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 2004, Jan-01, Volume: 10, Issue:1 Pt 1 Topics: Adenocarcinoma; Animals; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cyclosporine; Disease Progression; Drug Therapy, Combination; Humans; Immunosuppressive Agents; In Vitro Techniques; Lung Neoplasms; Male; Mice; Mice, Inbred DBA; Sirolimus; Tumor Cells, Cultured	2004
[Reduced intensity stem cell transplantation for metastatic renal cell carcinoma]. Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 2004, Volume: 95, Issue:3 Topics: Adult; Busulfan; Carcinoma, Renal Cell; Cyclosporine; Fatal Outcome; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Kidney Neoplasms; Lung Neoplasms; Male; Methotrexate; Middle Aged; Salvage Therapy; Stem Cell Transplantation; Transplantation Chimera; Transplantation Conditioning; Vidarabine	2004
Cyclosporin A aerosol improves the anticancer effect of paclitaxel aerosol in mice. Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine, 2004,Spring, Volume: 17, Issue:1 Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Renal Cell; Cyclosporine; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Synergism; Kidney Neoplasms; Liposomes; Lung Neoplasms; Mice; Paclitaxel	2004
Cyclosporine A mediates fibroproliferation through epithelial cells. Transplantation, 2004, Jun-27, Volume: 77, Issue:12 Topics: Adenocarcinoma; Cell Division; Cell Line, Tumor; Culture Media, Conditioned; Cyclosporine; Fibroblasts; Humans; Immunosuppressive Agents; Lung Neoplasms; Respiratory Mucosa; Tacrolimus	2004
Thermodynamic analysis of cyclosporin a binding to cyclophilin a in a lung tumor tissue lysate. Analytical chemistry, 2004, Aug-01, Volume: 76, Issue:15 Topics: Cyclophilin A; Cyclosporine; Humans; Kinetics; Lung Neoplasms; Thermodynamics	2004
Efficacy of five human melanocytic cell lines in experimental rabbit choroidal melanoma. Melanoma research, 2005, Volume: 15, Issue:1 Topics: Animals; Body Weight; Cell Line, Tumor; Choroid Neoplasms; Cyclosporine; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Lung Neoplasms; Male; Melanocytes; Melanoma, Experimental; Penicillin G; Rabbits; Skin Neoplasms; Survival Rate	2005
An unusual presentation of anti-Jo-1 syndrome, mimicking lung metastases, with massive pleural and pericardial effusions. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2006, Volume: 12, Issue:2 Topics: Adult; Antibodies, Antinuclear; Cyclophosphamide; Cyclosporine; Diagnosis, Differential; Female; Foot Dermatoses; Glucocorticoids; Hand Dermatoses; Humans; Immunosuppressive Agents; Lung Neoplasms; Pericardial Effusion; Pleural Effusion; Polymyositis; Prednisone; Syndrome	2006
Cyclosporin A aerosol improves the anticancer effect of paclitaxel aerosol in mice. Transactions of the American Clinical and Climatological Association, 2004, Volume: 115 Topics: Administration, Inhalation; Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Renal Cell; Cell Line, Tumor; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Liposomes; Lung Neoplasms; Mice; Mice, Inbred BALB C; Paclitaxel	2004
[Molecular mechanism of anti-apoptotic action of survivin in NCI-H446 lung cancer cells]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2006, Volume: 28, Issue:6 Topics: Apoptosis; Caspase 9; Cell Line, Tumor; Cell Proliferation; Cyclosporine; Cytochromes c; Cytosol; Down-Regulation; Humans; Immunosuppressive Agents; Inhibitor of Apoptosis Proteins; Lung Neoplasms; Membrane Potential, Mitochondrial; Microtubule-Associated Proteins; Neoplasm Proteins; Oligodeoxyribonucleotides, Antisense; RNA, Messenger; Survivin; Transfection	2006
[Treatment of metastatic osteosarcoma with verapamil, cyclosporine and chemotherapy. A case report]. Minerva pediatrica, 1995, Volume: 47, Issue:4 Topics: Bone Neoplasms; Chemotherapy, Adjuvant; Child; Combined Modality Therapy; Cyclosporine; Femur; Humans; Lung; Lung Neoplasms; Male; Neoplasm Metastasis; Neoplasm Staging; Osteosarcoma; Verapamil	1995
Recurrent lymphoma in a cardiac allograft recipient. Transplantation science, 1994, Volume: 4, Issue:1 Topics: Azathioprine; Cyclosporine; Follow-Up Studies; Graft Rejection; Heart Transplantation; Humans; Lung Neoplasms; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Transplantation, Homologous	1994
The effects of cyclosporine on the pharmacokinetics of doxorubicin in patients with small cell lung cancer. Cancer, 1995, Mar-01, Volume: 75, Issue:5 Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Small Cell; Cyclosporine; Down-Regulation; Doxorubicin; Drug Resistance, Multiple; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms	1995
The riminophenazine agents clofazimine and B669 reverse acquired multidrug resistance in a human lung cancer cell line. Cancer letters, 1994, Sep-30, Volume: 85, Issue:1 Topics: Anti-Infective Agents; Antineoplastic Agents; Carbon Radioisotopes; Carcinoma, Small Cell; Cell Division; Clofazimine; Cyclosporine; Drug Interactions; Drug Resistance, Multiple; Humans; Lung Neoplasms; Tumor Cells, Cultured; Vinblastine	1994
Effects of amiodarone, cyclosporin A, and PSC 833 on the cytotoxicity of mitoxantrone, doxorubicin, and vincristine in non-P-glycoprotein human small cell lung cancer cell lines. Cancer research, 1994, Oct-15, Volume: 54, Issue:20 Topics: Amiodarone; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Small Cell; Cyclosporine; Cyclosporins; Doxorubicin; Drug Resistance, Multiple; Drug Screening Assays, Antitumor; Drug Synergism; Humans; Lung Neoplasms; Mitoxantrone; Tumor Cells, Cultured; Vincristine	1994
A comparison of rhodamine 123 accumulation and efflux in cells with P-glycoprotein-mediated and MRP-associated multidrug resistance phenotypes. European journal of cancer (Oxford, England : 1990), 1994, Volume: 30A, Issue:9 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cyclosporine; Drug Resistance, Multiple; Flow Cytometry; Hot Temperature; Humans; Lung Neoplasms; Mammary Neoplasms, Animal; Mice; Mitochondria; Phenotype; Rhodamine 123; Rhodamines; Time Factors; Tumor Cells, Cultured	1994
The effects of cyclosporine on the pharmacokinetics of doxorubicin in patients with small cell lung cancer. Cancer, 1994, Aug-01, Volume: 74, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Cyclosporine; Doxorubicin; Drug Therapy, Combination; Female; Humans; Leukocyte Count; Lung Neoplasms; Male; Middle Aged; Platelet Count; Vincristine	1994
Drug resistance and its counteraction by cyclosporin A in function of metastatic potential in the Lewis lung carcinoma system. Cellular and molecular biology (Noisy-le-Grand, France), 1994, Volume: 40, Issue:4 Topics: Animals; Carcinoma; Cyclosporine; Disease Models, Animal; Doxorubicin; Drug Resistance; Lung Neoplasms; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Tumor Cells, Cultured	1994
Selective toxicity of TGF-alpha-PE40 to EGFR-positive cell lines: selective protection of low EGFR-expressing cell lines by EGF. British journal of cancer, 1994, Volume: 69, Issue:6 Topics: Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cell Division; Cell Line; Cyclosporine; Dose-Response Relationship, Drug; Drug Interactions; Epidermal Growth Factor; ErbB Receptors; Exotoxins; Female; Humans; Lung Neoplasms; Recombinant Fusion Proteins; Recombinant Proteins; Tamoxifen; Transforming Growth Factor alpha; Tumor Cells, Cultured; Verapamil	1994
Chemosensitisation and drug accumulation effects of cyclosporin A, PSC-833 and verapamil in human MDR large cell lung cancer cells expressing a 190k membrane protein distinct from P-glycoprotein. European journal of cancer (Oxford, England : 1990), 1993, Volume: 29A, Issue:3 Topics: Carcinoma, Non-Small-Cell Lung; Cyclosporine; Cyclosporins; Daunorubicin; Humans; Lung Neoplasms; Membrane Proteins; Molecular Weight; Neoplasm Proteins; Tumor Cells, Cultured; Verapamil; Vincristine	1993
Enhancement of metastasis of prostate adenocarcinoma cells by immune-suppressive cyclosporine A. Cancer letters, 1997, Jan-01, Volume: 111, Issue:1-2 Topics: Adenocarcinoma; Animals; Cyclosporine; Immunosuppressive Agents; Lung Neoplasms; Lymphatic Metastasis; Male; Prostatic Neoplasms; Rats; Rats, Wistar; Specific Pathogen-Free Organisms	1997
Superiority of cyclosporin A over PSC-833 in enhancement of VP-16 efficacy in murine tumors in vivo. Cancer chemotherapy and pharmacology, 1997, Volume: 39, Issue:5 Topics: Animals; Antineoplastic Agents, Phytogenic; Cyclosporine; Cyclosporins; Drug Synergism; Etoposide; Female; Immunosuppressive Agents; Leukemia L1210; Lung Neoplasms; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Survival Rate; Time Factors	1997
Isolation from a human MDR lung cell line of multiple clonal subpopulations which exhibit significantly different drug resistance. International journal of cancer, 1997, May-29, Volume: 71, Issue:5 Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Division; Cell Separation; Clone Cells; Cyclosporine; DNA Topoisomerases, Type II; Doxorubicin; Drug Resistance, Multiple; Humans; Isoenzymes; Lung Neoplasms; Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured; Verapamil	1997
The multidrug-resistant human lung tumour cell line, DLKP-A10, expresses novel drug accumulation and sequestration systems. Biochemical pharmacology, 1997, May-15, Volume: 53, Issue:10 Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Western; Calcium Channel Blockers; Cyclosporine; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Lung Neoplasms; Tumor Cells, Cultured; Verapamil; Vincristine	1997
Kaposi's sarcoma as manifestation of immunosuppression in organ transplant recipients. Dermatology (Basel, Switzerland), 1997, Volume: 195, Issue:1 Topics: Anti-Inflammatory Agents; Azathioprine; Combined Modality Therapy; Cyclosporine; Graft Rejection; Heart Transplantation; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Lung Neoplasms; Male; Middle Aged; Neoplasms, Multiple Primary; Prednisone; Remission Induction; Sarcoma, Kaposi; Skin Neoplasms; Stomach Neoplasms	1997
Multidrug resistance modulation in rhabdomyosarcoma and neuroblastoma cell lines. International journal of oncology, 1998, Volume: 12, Issue:5 Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Small Cell; Cell Survival; Cisplatin; Cyclophosphamide; Cyclosporine; Doxorubicin; Drug Resistance, Multiple; Etoposide; Humans; Kinetics; Lung Neoplasms; Methotrexate; Neuroblastoma; Rhabdomyosarcoma; Time Factors; Tumor Cells, Cultured; Verapamil; Vincristine	1998
Alpha-tocopherol antagonizes the multidrug-resistance-reversal activity of cyclosporin A, verapamil, GF120918, clofazimine and B669. Cancer letters, 1998, May-15, Volume: 127, Issue:1-2 Topics: Acridines; Cell Death; Clofazimine; Cyclosporine; Drug Resistance, Multiple; Humans; Isoquinolines; Lung Neoplasms; Tetrahydroisoquinolines; Tumor Cells, Cultured; Verapamil; Vinblastine; Vitamin E	1998
Cyclosporine A-associated thrombotic thrombocytopenic purpura following lung transplantation. Transplantation proceedings, 1998, Volume: 30, Issue:4 Topics: Aged; Cyclosporine; Emphysema; Female; Humans; Immunosuppressive Agents; Lung Neoplasms; Lung Transplantation; Lymphangioleiomyomatosis; Male; Middle Aged; Purpura, Thrombotic Thrombocytopenic	1998
Breast and lung cancers in two cyclosporin-A-treated psoriatic women. Dermatology (Basel, Switzerland), 1998, Volume: 196, Issue:4 Topics: Adult; Breast Neoplasms; Cyclosporine; Female; Humans; Immunosuppressive Agents; Lung Neoplasms; Middle Aged; Psoriasis	1998
Circumvention of multidrug resistance by a quinoline derivative, MS-209, in multidrug-resistant human small-cell lung cancer cells and its synergistic interaction with cyclosporin A or verapamil. Cancer chemotherapy and pharmacology, 1998, Volume: 42, Issue:6 Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Small Cell; Cyclosporine; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Humans; Lung Neoplasms; Quinolines; Tumor Cells, Cultured; Verapamil	1998
Effects of cytoskeletal inhibitors on the accumulation of vincristine in a resistant human lung cancer cell line with high level of polymerized tubulin. Cancer biochemistry biophysics, 1998, Volume: 16, Issue:4 Topics: Adenocarcinoma; Cell Survival; Colchicine; Cyclosporine; Cytochalasin B; Cytochalasin D; Cytoskeleton; Drug Resistance, Neoplasm; Drug Synergism; Humans; Lung Neoplasms; Neoplasm Proteins; Paclitaxel; Tubulin; Tumor Cells, Cultured; Verapamil; Vincristine	1998
Effect of systemic cyclosporine on tumor recurrence after liver transplantation in a model of hepatocellular carcinoma. Transplantation, 1999, Feb-27, Volume: 67, Issue:4 Topics: Animals; Cyclosporine; Disease Models, Animal; Immunosuppressive Agents; Liver Neoplasms, Experimental; Liver Transplantation; Lung Neoplasms; Male; Neoplasm Recurrence, Local; Neoplasm Transplantation; Rats; Rats, Inbred ACI; Survival Rate	1999
Cyclosporine induces the expression of the cyclin inhibitor p21. Transplantation, 1999, May-15, Volume: 67, Issue:9 Topics: Adenocarcinoma; Antibodies; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinases; Cyclins; Cyclosporine; Enzyme Inhibitors; Humans; Immunosuppressive Agents; Lung Neoplasms; Promoter Regions, Genetic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; T-Lymphocytes; Transfection; Transforming Growth Factor beta; Tumor Cells, Cultured	1999
A new in vivo method to study P-glycoprotein transport in tumors and the blood-brain barrier. Cancer research, 1999, May-15, Volume: 59, Issue:10 Topics: Animals; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Brain Chemistry; Calcium Channel Blockers; Carcinoma, Small Cell; Cyclosporine; Daunorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Lung Neoplasms; Male; Metabolic Clearance Rate; Neoplasm Proteins; Neoplasm Transplantation; Neoplasms; Rats; Rats, Nude; Recombinant Fusion Proteins; Tissue Distribution; Tumor Cells, Cultured; Verapamil	1999
Dexamethasone and cyclosporin A do not inhibit interleukin-15 expression in the human lung carcinoma cell line A549. European cytokine network, 2000, Volume: 11, Issue:3 Topics: Cyclosporine; Dexamethasone; Gene Expression Regulation, Neoplastic; Humans; Interleukin-1; Interleukin-15; Interleukin-8; Lung Neoplasms; Polymerase Chain Reaction; RNA, Messenger; Transcription, Genetic; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha	2000
Multisystem Langerhans-cell histiocytosis with life-threatening pulmonary involvement--good response to cyclosporine A. Medical and pediatric oncology, 2000, Volume: 35, Issue:4 Topics: Cyclosporine; Diagnosis, Differential; Female; Histiocytosis, Langerhans-Cell; Humans; Immunosuppressive Agents; Infant; Lung Neoplasms; Pneumothorax; Radiography	2000
Uveal melanoma model with metastasis in rabbits: effects of different doses of cyclosporine A. Current eye research, 2000, Volume: 21, Issue:3 Topics: Alanine Transaminase; Animals; Blood Urea Nitrogen; Body Weight; Creatinine; Cyclosporine; Follow-Up Studies; Immunosuppression Therapy; Immunosuppressive Agents; Kidney; Lung Neoplasms; Male; Melanoma, Experimental; Rabbits; Survival Rate; Tumor Cells, Cultured; Uveal Neoplasms	2000
Effects of cyclosporin A and a non-immunosuppressive analogue, O-acetyl cyclosporin A, upon the growth of parent and multidrug resistant human lung cancer cells in vitro. British journal of cancer, 1992, Volume: 65, Issue:3 Topics: Adenocarcinoma; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cell Division; Cell Line; Cell Survival; Cyclosporine; Cyclosporins; Dose-Response Relationship, Drug; Drug Resistance; Eflornithine; Humans; In Vitro Techniques; Lung Neoplasms; Putrescine; Spermidine; Spermine	1992
Multidrug resistance in a small cell lung cancer line: rapid selection with etoposide and differential chemosensitization with cyclosporin A. Anti-cancer drugs, 1992, Volume: 3, Issue:4 Topics: Alkalies; Biological Transport; Carcinoma, Small Cell; Cell Division; Cell Nucleus; Cyclosporine; DNA Topoisomerases, Type II; Drug Resistance; Etoposide; Lung Neoplasms; Organelles; Phenotype; Ribonucleases; Tumor Cells, Cultured	1992
Enhancement by cyclosporin A of metastasis from hamster cheek pouch carcinoma. Archives of oral biology, 1992, Volume: 37, Issue:7 Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Carcinoma, Squamous Cell; Cocarcinogenesis; Cricetinae; Cyclosporine; Lung Neoplasms; Lymphatic Metastasis; Male; Mesocricetus; Mouth Neoplasms; Neck; Neoplasm Invasiveness; Neoplasm Staging; Time Factors	1992